Madrigal Pharmaceuticals
MDGL
MDGL
97 hedge funds and large institutions have $148M invested in Madrigal Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 13 closing their positions.
Holders
97
Holders Change
+6
Holders Change %
+6.59%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
38
Reduced
24
Closed
13
Calls
$695K
Puts
$1.01M
Net Calls
-$314K
Net Calls Change
+$11K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBA
101
Baker Bros. Advisors
New York
| – | – | -489,053 | Closed |
|
|
SM
102
Sabby Management
Miami Beach,
Florida
| – | – | -399,000 | Closed |
|
103
Tudor Investment Corp
Stamford,
Connecticut
| – | – | -200,000 | Closed |
|
|
BACM
104
Blue Arrow Capital Management
New York
| – | – | -199,930 | Closed |
|
|
GL
105
GLG LLC
New York
| – | – | -50,000 | Closed |
|
|
GCP
106
GSA Capital Partners
London,
United Kingdom
| – | – | -31,300 | Closed |
|
|
PP
107
Paloma Partners
Greenwich,
Connecticut
| – | – | -19,288 | Closed |
|
|
TSS
108
Two Sigma Securities
New York
| – | – | -11,721 | Closed |
|
|
TRCT
109
Tower Research Capital (TRC)
New York
| – | – | -6,476 | Closed |
|
|
ST
110
Spot Trading
Chicago,
Illinois
| $0 | 200 | +200 | New |
|